STAA (STAAR Surgical Corp) Market Value to Book Value Ratio

STAAR Surgical Corp (STAA) - corporate logo

Scaling sales in Asia activates operating leverage, reducing the cost of goods sold while maintaining high gross margins. This chart of current share prices on GURU.Markets confirms STAAR Surgical Company (STAA) as the leader in implantable lenses, where a technological edge ensures excellent profitability and stable FCF. Surgeon loyalty to the unique instrumentation guarantees high-margin revenue, which currently stands at 3.37.

STAA - STAAR Surgical Co Market-to-Book Ratio over the range 07/04/2022 - 10/29/2026

STAA (STAAR Surgical Co.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price STAAR Surgical Company|STAA - Analyst Consensus Forecast
- market capitalization data:
Market Value STAAR Surgical Corp|STAA - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share STAAR Surgical|STAA - Total Stockholders' Equity|Market Capitalization to Book Value Ratio staar.com|STAA - Total Business Assets
- debt and liquidity data:
Total Debt to Capital STAAR Surgical Company|STAA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital STAAR Surgical Corp|STAA - Company Total Debt|Debts to Book Capitalization STAAR Surgical Corp|STAA - Company Long-Term Debts|Company Short-Term Debt STAAR Surgical
Initial company analysis:STAAR Surgical Company - STAA
Manufactured products of STAAR Surgical Co.

To identify fundamental stability drivers, the investor analyzes the price-to-book ratio, which allows for an assessment of the business's current premium over its book value. This metric, representing the excess of market value over balance sheet capital, reflects market confidence in the capitalization of STAAR Surgical Company (STAA) ESG initiatives regarding medical waste optimization and strict adherence to bioethical manufacturing standards.

Direct competitors

ISRG: Market Capitalization to Book Value Ratio|DHR (danaher.com) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio Chromadex Corp NAGE|Market Cap to Net Assets Ratio ZimVie Dental|Market Value to Book Value AngioDynamics Inc. ANGO|Market Capitalization to Book Value Ratio CERS (Cerus Corporation)|TKNO: Market Capitalization to Book Value|Market Value to Book Value Ratio Monogram Orthopedics|STSS (Sharps Technology) - Capitalization to Book Value Ratio|INFU: Market Value to Book Value Ratio|Market Capitalization to Book Value Utah Med (UTMD)|Market Cap to Net Assets Ratio KORU Medical Systems|Market Cap to Book Value Multiple NYXH (nyxoah.com)|Market Value to Book Value Ratio Microbot Medical|PDEX - Market Value to Book Value|Zentek Limited - Market Cap to Net Assets Ratio|ELUT: Market Capitalization to Book Value Ratio|MLSS (Milestone Scientific) - Market Value to Book Value Ratio|nexgel.com (NXGL) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO: Market Capitalization to Book Value